Temperature Responsive Arginine-based Hydrogels as Biologics Carriers
- 详细技术说明
- Thermo-sensitive and biodegradable copolymeric hydrogels were derived from arginine based unsaturated poly(ester-amide) (Arg-UPEA) and other biocompatible precursors prepared by photo-polymerization.
- *Abstract
-
Cornell researchers developed novel thermo-sensitive and biodegradable copolymeric hydrogels derived from arginine based unsaturated poly(ester-amide) (Arg-UPEA) and other biocompatible precursors prepared by photo-polymerization. The photo crosslinked hydrogels exhibit slow degradation, a gradually decreased swelling ratio with increased temperature, and were shown to be thermally-responsive when the temperature was cycled over a wide range of temperatures.
Paclitaxel, a model anti-cancer drug, was pre-loaded in the hydrogels to attain the following bi-phasic molecule release profiles: 1) a burst-free and rapid controlled release profile was initially observed for a one week period and 2) a much slower sustained release was followed thereafter. The release rates can be controlled by varying the hybrid ratio of the two precursors during photo-polymerization.
Plasmid DNA was pre-loaded in the hydrogels for sustained delivery, and a wide range of release profiles was observed by varying one of the building blocks in Arg-UPEA. The overall release rate can be controlled by adjusting the photo crosslinking time and the hybrid ratio.
The novel hydrogels were also shown to provide for sustained cytokine (IL-12) delivery for cancer immunotherapy over almost three months.
Potential Applications
- Biomaterials and biomedical engineering practices
- drug or biologics delivery carriers
- cytokine delivery (e.g., immunotherapy of cancer)
- gene delivery carrier for gene therapy
- tissue engineering scaffolds
- biomedical devices (disposables or artificial organs, e.g., blood vessels)
- contact lenses, muscle models, and artificial cartilage
Advantages
- Good solubility in all polar solvents, including water
- Fabricated from water-soluble macromer precursors to eliminate adverse organic solvent effect
- Simple synthesis; no laborious protecing/deprotecting multi-steps of functioning group needed
- Nontoxic, biocompatible, and biodegradable
- Made from FDA-approved raw materials that are widely used in clinical practice
- Allows delivery of bioactive cytokine(s) directly into tumor microenvironment
- Avoids "encapsulation", a major factor responsible for loss of bioactivity in drug delivery
- Allows design of a wide range of release kinetics
- Biomaterials and biomedical engineering practices
- *Licensing
- Martin Teschlmt439@cornell.edu(607) 254-4454
- 其他
-
Patent Applications: PCT/US08/84934; 08 858 090.7
- 国家/地区
- 美国
